Implications of Correlation Between PBRM1 and PD-L1 Expression in Renal Cell Carcinoma, Clear Cell Type

被引：0
|
作者：
Lee, Jieun [1 ]
Choe, Gheeyoung [1 ]
Lee, Kyu Sang [1 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Seongnamsi, South Korea
来源：
MODERN PATHOLOGY | 2022年 / 35卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
575
引用
收藏
页码：617 / 617
页数：1
相关论文
共 50 条
  • [31] Clinicopathological correlation and prognostic value of PD-L1 expression in renal cell carcinoma
    Elkhodary, Hoda Sayed
    Nasr, Khaled E.
    Ahmed, Sherif H.
    Shakweer, Marwa M.
    Ezz-Eldin, Mai M. A.
    IMMUNOPATHOLOGIA PERSA, 2022, 8 (02):
  • [32] A germline mutation in PBRM1 predisposes to renal cell carcinoma
    Benusiglio, Patrick R.
    Couve, Sophie
    Gilbert-Dussardier, Brigitte
    Deveaux, Sophie
    Le Jeune, Helene
    Da Costa, Melanie
    Fromont, Gaelle
    Memeteau, Francoise
    Yacoub, Mokrane
    Coupier, Isabelle
    Leroux, Dominique
    Mejean, Arnaud
    Escudier, Bernard
    Giraud, Sophie
    Gimenez-Roqueplo, Anne-Paule
    Blondel, Christophe
    Frouin, Eric
    Teh, Bin T.
    Ferlicot, Sophie
    Bressac-de Paillerets, Brigitte
    Richard, Stephane
    Gad, Sophie
    JOURNAL OF MEDICAL GENETICS, 2015, 52 (06) : 426 - 430
  • [33] Association between PD-L1 Expression and the Prognosis and Clinicopathologic Features of Non-Clear Cell Renal Cell Carcinoma
    Chrabanska, Magdalena
    Szweda-Gandor, Nikola
    Rynkiewicz, Magdalena
    Hrabos, Dominik
    Drozdzowska, Bogna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [34] Relationship between body composition and PBRM1 mutations in clear cell renal cell carcinoma: a propensity score matching analysis
    Demirel, Emin
    Dilek, Okan
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (05):
  • [35] Prognostic impact of concomitant loss of PBRM1 and BAP1 protein expression in early stages of clear cell renal cell carcinoma
    da Costa, Walter Henriques
    da Cunha, Isabela Werneck
    Fares, Aline Fusco
    Bezerra, Stephania M.
    Shultz, Luciana
    Clavijo, Diego Abreu
    da Silva, Deusdedit Vieira
    Netto, George Jabboure
    Guimaraes, Gustavo Cardoso
    Zequi, Stenio de Cassio
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (05) : 243.e1 - 243.e8
  • [36] The Suggested Importance of PBRM1 Mutation in Predicting Postoperative Recurrence of Localized Clear Cell Renal Cell Carcinoma
    Goldberg, Hanan
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (04) : 1889 - 1891
  • [37] PD-L1 expression in nonclear-cell renal cell carcinoma
    Choueiri, T. K.
    Fay, A. P.
    Gray, K. P.
    Callea, M.
    Ho, T. H.
    Albiges, L.
    Bellmunt, J.
    Song, J.
    Carvo, I.
    Lampron, M.
    Stanton, M. L.
    Hodi, F. S.
    McDermott, D. F.
    Atkins, M. B.
    Freeman, G. J.
    Hirsch, M. S.
    Signoretti, S.
    ANNALS OF ONCOLOGY, 2014, 25 (11) : 2178 - 2184
  • [38] The Suggested Importance of PBRM1 Mutation in Predicting Postoperative Recurrence of Localized Clear Cell Renal Cell Carcinoma
    Hanan Goldberg
    Annals of Surgical Oncology, 2021, 28 : 1889 - 1891
  • [39] Polybromo-1 (PBRM1), a SWI/SNF complex subunit is a prognostic marker in clear cell renal cell carcinoma
    da Costa, Walter H.
    Rezende, Mariana
    Carneiro, Felipe C.
    Rocha, Rafael M.
    da Cunha, Isabela W.
    Carraro, Dirce M.
    Guimaraes, Gustavo C.
    Zequi, Stenio de Cassio
    BJU INTERNATIONAL, 2014, 113 (5B) : E157 - E163
  • [40] Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC)
    Abbas, M.
    Steffens, S.
    Bellut, M.
    Eggers, H.
    Grosshennig, A.
    Becker, J. U.
    Wegener, G.
    Schrader, A. J.
    Gruenwald, V.
    Ivanyi, P.
    MEDICAL ONCOLOGY, 2016, 33 (07)
12345